Nagendran Sukumar Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$83,500.00
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Nagendran Sukumar

According to the SEC Form 4 filings, Nagendran Sukumar, being in a position of

  1. President and Head of R&D at Taysha Gene Therapies, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 1086222 shares for $5.33M,
    over all time since 2022-02-02, has bought 15000 shares for $83,500, and sold 1343276 shares for $6.13M.

Biography of Nagendran Sukumar

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $5,325,3757100

Comparison of Insiders on Amount of Buys and Sells

2026-07-10SaleTaysha Gene Therapies, Inc.
TSHA
President and Head of R&D
200,000
0.0759%
$6.24$1.25M-15.14%
2026-04-10SaleTaysha Gene Therapies, Inc.
TSHA
President and Head of R&D
200,000
0.077%
$4.46$892,000+28.06%
2026-01-26SaleTaysha Gene Therapies, Inc.
TSHA
President and Head of R&D
26,918
0.011%
$4.61$124,092+14.41%
2026-01-23SaleTaysha Gene Therapies, Inc.
TSHA
President and Head of R&D
89,132
0.0381%
$4.75$423,377+15.67%
2026-01-12SaleTaysha Gene Therapies, Inc.
TSHA
President and Head of R&D
200,000
0.0741%
$4.71$942,000+6.48%
2025-12-01SaleTaysha Gene Therapies, Inc.
TSHA
President and Head of R&D
260,047
0.1012%
$4.51$1.17M+20.77%
2025-11-28SaleTaysha Gene Therapies, Inc.
TSHA
President and Head of R&D
110,125
0.0422%
$4.75$523,094+12.66%
2025-09-10SaleTaysha Gene Therapies, Inc.
TSHA
President and Head of R&D
200,000
0.0837%
$3.23$646,000+58.46%
2025-08-21SaleTaysha Gene Therapies, Inc.
TSHA
President and Head of R&D
57,054
0.0239%
$2.85$162,604+72.82%
2023-05-16PurchaseTaysha Gene Therapies, Inc.
TSHA
President and Head of R&D
5,000
0.0078%
$0.68$3,400+172.4%
2022-02-02PurchaseTaysha Gene Therapies, Inc.
TSHA
director
10,000
0.0274%
$8.01$80,100-57.83%
Total: 11
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.